Status:
COMPLETED
Extravascular Lung Water Monitoring by Combined Ultrasound and Bioimpedance as a Guide for Treatment in Hemodialysis Patients
Lead Sponsor:
Grigore T. Popa University of Medicine and Pharmacy
Conditions:
Patients on Hemodialysis for More Than 3 Months
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients will be selected from the Dialisys Centers in Iasi, Romania. Patients will be randomized 1:1 to have a dry-weight assessment based on clinical (control) or lung US and bioimpedance (active) g...
Eligibility Criteria
Inclusion
- patients in hemodialysis for more than 3 months, that have no absolute contraindication for for performing bioimpedance measurements (amputation, stent, pregnancy, severe ascites) and ultrasound lung comets measurements (persistent pleuresia, pulmonary fibrosis, pneumectomy).
Exclusion
- Patients with metallic joint prostheses, cardiac pacemakers, decompensated cirrhosis, limb amputations and severe conditions with life expectations \<1 year
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT01815762
Start Date
March 1 2013
End Date
August 1 2015
Last Update
March 2 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital "Dr. C.I. Parhon", Iasi, Department of Nephrology
Iași, Iaşi, Romania, 700503